Skip to content

Clinical trials

Phase 1 Cardiovascular Diseases trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cardiovascular Diseases Phase: Phase 1 Clear all

191 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20032
20047
20052
20063
200710
20086
200913
201010
20117
20124
20136
20148
20156
20169
20178
201812
201910
202016
202111
20228
20238
20249
20254
20269

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed138
Unknown status22
Recruiting14
Terminated8
Not yet recruiting4
Withdrawn3
Enrolling by invitation1
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca14
Chong Kun Dang Pharmaceutical10
Amgen6
National Heart, Lung, and Blood Institute (NHLBI)6
GlaxoSmithKline5
The University of Texas at Arlington5
Bial - Portela C S.A.3
Humanis Saglık Anonim Sirketi3
Northwestern University3
Penn State University3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cardiovascular Diseases191
Vascular Diseases15
Hypertension13
Obesity13
Heart Diseases12
Atherosclerosis11
Diabetes Mellitus, Type 211
Heart Failure11
Diabetes Mellitus9
Coronary Artery Disease7

Trials

Showing 51 to 75 of 191. Each trial links to its page on Pharma Observatory.

91 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.